SS-31 and Cardiolipin: A Mitochondrial Research Framework

Mitochondrial experiments can examine either signalling around the organelle or the membrane structures that support energy production. SS-31 belongs principally to the latter research framework: this cell-permeable tetrapeptide is studied for its interaction with cardiolipin in the inner mitochondrial membrane.

Why membrane organisation matters

Cardiolipin helps organise the membrane environment in which electron transport and oxidative phosphorylation occur. SS-31 research investigates whether its interaction with this phospholipid supports cristae architecture and electron-transport-chain function under stress.

This provides a different mechanistic emphasis from simple, stoichiometric scavenging of reactive oxygen species. The proposed effect concerns membrane organisation and the coupling of mitochondrial processes, rather than merely removing oxidants after they form.

Preclinical investigations span cardiovascular, renal, ophthalmic and skeletal-muscle models. Findings in damaged or aged mitochondria remain experimental observations, not evidence of a benefit in people.

Choosing informative comparators

SS-31 has been used as a reference intervention in mitochondrial-dysfunction experiments. Comparisons with CoQ10, MitoQ, Humanin or MOTS-c can help separate membrane-associated effects from broader mitochondrial signalling.

Localisation is another relevant distinction. SS-31's cardiolipin interaction differs from targeting approaches that rely primarily on membrane potential. Researchers should therefore avoid assuming that all mitochondria-targeted compounds reach or affect the organelle in the same way.

Protein-interaction studies also contribute to the proposed mechanistic picture. Such findings support further investigation but do not make every downstream functional effect certain across models.

Laboratory material and catalogue context

SS-31 is described as water-soluble, although preparation and handling still need to suit the validated assay. Review available chromatographic characterisation, mass-spectrometric identity data and batch documentation rather than inferring material quality from a product description.

The SS-31 reference profile provides compound-specific context; Regena lists 10 mg, 30 mg and 50 mg vial formats. The MOTS-c research overview offers a signalling-focused comparator, while the wider peptide range provides further catalogue context.

SS-31 is for laboratory research only, including in-vitro and appropriate animal studies. It is not for human consumption or therapeutic use.